Intrahepatic Cholangiocarcinoma Clinical Trials

168 clinical trials for Intrahepatic Cholangiocarcinoma across international registries, including 51 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury — RECRUITING · NA
• Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases — RECRUITING · PHASE1
• Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC) — RECRUITING · NA
• The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer — RECRUITING · PHASE2
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma — RECRUITING · PHASE2
• An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer — RECRUITING
• Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) — RECRUITING · NA
• A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors — RECRUITING · PHASE1
• A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE1
• A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC — RECRUITING · PHASE2
• Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study — RECRUITING
• Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN — RECRUITING · NA
• A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement — RECRUITING · PHASE2
• Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery — RECRUITING · PHASE2
• Scout Dose of Resin Microspheres — RECRUITING · NA
• Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy — RECRUITING · NA
• Liver Transplantation in Intrahepatic Cholangiocarcinoma — RECRUITING
• Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) — RECRUITING · PHASE2
• REGULUS: MRI-guided Adaptive SABR for Liver Cancers — RECRUITING · PHASE2
• Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy — RECRUITING · PHASE2
• HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) — RECRUITING · PHASE2
• Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers — RECRUITING
• A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening — RECRUITING
• Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer. — RECRUITING
• A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC — RECRUITING
• Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection — RECRUITING · PHASE1
• PERIOPERATIVE THERAPY WITH GEMCITABINE/CISPLATIN/NAB-PACLITAXEL AND RILVEGOSTOMIG (AZD2936) FOR PATIENTS WITH RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA (ICCA) - A PHASE II TRIAL (NEOLANGIO) — RECRUITING · PHASE2
• A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients — RECRUITING · PHASE1
• Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study — RECRUITING · PHASE3
• Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery — RECRUITING · PHASE2
• Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments — RECRUITING
• Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors — RECRUITING · PHASE2
• Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer — RECRUITING · PHASE2
• TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer — RECRUITING · PHASE2
• Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence — RECRUITING · PHASE2
• Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Utilizing Discarded Livers from Donors with a History of Cancer for Patients Lacking Access to Standard Allocation: A Compassionate Use Exploratory Study — RECRUITING
• An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC — RECRUITING · PHASE2
• A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
• LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA) — RECRUITING · NA
• Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial) — RECRUITING · NA

Refine this search